Like us, other researchers have assessed the effect of different antihyperglycemic medications (insulin, metformin, sulfonylureas, thiazolidinediones, alpha-glucosidase inhibitors, non-sulfonylurea insulin secretory analogues) on gastric cancer risk [23]. This evidence concerns the gene INS and gastric cancer.